{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:32:19Z","timestamp":1713573139109},"reference-count":29,"publisher":"Consilium Medicum","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/terarkh201587683-87","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T17:39:00Z","timestamp":1460655540000},"page":"83","source":"Crossref","is-referenced-by-count":5,"title":["Efficiency of tacrolimus therapy for perianal Crohn\u2019s disease"],"prefix":"10.26442","volume":"87","author":[{"given":"B. A.","family":"Nanaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Vardanyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. L.","family":"Khalif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201587683-87-1","doi-asserted-by":"crossref","unstructured":"Crohn B.B., Ginzberg L., Oppenheimer G.D. Regional ileitis: a pathologic and clinical entity. JAMA 1932; 99: 1323.","DOI":"10.1001\/jama.1932.02740680019005"},{"key":"key-10.17116\/terarkh201587683-87-2","doi-asserted-by":"crossref","unstructured":"Hellers G., Bergstrand O., Ewerth S. Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease. Gut 1980; 21 (6): 525\u2014527.","DOI":"10.1136\/gut.21.6.525"},{"key":"key-10.17116\/terarkh201587683-87-3","doi-asserted-by":"crossref","unstructured":"Sandborn W.J., Fazio V.W., Feagan B.G. et al. AGA technical review on perianal Crohn\u2019s disease. Gastroenterology 2003; 125 (5): 1508\u20141530.","DOI":"10.1016\/j.gastro.2003.08.025"},{"key":"key-10.17116\/terarkh201587683-87-4","doi-asserted-by":"crossref","unstructured":"Schwartz D.A., Loftus E.V., Tremaine W.J. et al. The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology 2002; 122 (4): 875\u2014880.","DOI":"10.1053\/gast.2002.32362"},{"key":"key-10.17116\/terarkh201587683-87-5","doi-asserted-by":"crossref","unstructured":"Linares L., Moreira L.F., Andrews H. et al. Natural history and treatment of anorectal strictures complicating Crohn\u2019s disease. Br J Surg 1988; 75 (7): 653\u2014655.","DOI":"10.1002\/bjs.1800750711"},{"key":"key-10.17116\/terarkh201587683-87-6","doi-asserted-by":"crossref","unstructured":"Penner A., Crohn B. Perianal fistulae as a complication of regional ileitis. Ann Surg 1938; 108: 867\u2014873.","DOI":"10.1097\/00000658-193811000-00007"},{"key":"key-10.17116\/terarkh201587683-87-7","doi-asserted-by":"crossref","unstructured":"McClane S.J., Rombeau J.L. Anorectal Crohn\u2019s disease. Surg Clin North Am 2001; 81 (1): 169\u2014183.","DOI":"10.1016\/S0039-6109(05)70279-6"},{"key":"key-10.17116\/terarkh201587683-87-8","doi-asserted-by":"crossref","unstructured":"Williams J.G., Rothenberger D.A., Nemer F.D. et al. Fistula-in-ano in Crohn\u2019s disease. Results of aggressive surgical treatment. Dis Colon Rectum 1991; 34 (5): 378\u2014384.","DOI":"10.1007\/BF02053687"},{"key":"key-10.17116\/terarkh201587683-87-9","doi-asserted-by":"crossref","unstructured":"Halme L., Sainio A.P. Factors related to frequency, type, and outcome of anal fistulas in Crohn\u2019s disease. Dis Colon Rectum 1995; 38 (1): 55\u201459.","DOI":"10.1007\/BF02053858"},{"key":"key-10.17116\/terarkh201587683-87-10","doi-asserted-by":"crossref","unstructured":"Sangwan Y.P., Schoetz D.J., Murray J.J. et al. Perianal Crohn\u2019s disease. Results of local surgical treatment. Dis Colon Rectum 1996; 39 (5): 529\u2014535.","DOI":"10.1007\/BF02058706"},{"key":"key-10.17116\/terarkh201587683-87-11","doi-asserted-by":"crossref","unstructured":"Faucheron J.L., Saint-Marc O., Guibert L. et al. Long-term seton drainage for high anal fistulas in Crohn\u2019s disease \u2014 a sphincter-saving operation? Dis Colon Rectum 1996; 39 (2): 208\u2014211.","DOI":"10.1007\/BF02068077"},{"key":"key-10.17116\/terarkh201587683-87-12","doi-asserted-by":"crossref","unstructured":"Pearl R.K., Andrews J.R., Orsay C.P. et al. Role of the seton in the management of anorectal fistulas. Dis Colon Rectum 1993; 36 (6): 573\u2014577.","DOI":"10.1007\/BF02049864"},{"key":"key-10.17116\/terarkh201587683-87-13","doi-asserted-by":"crossref","unstructured":"Keighley M.R., Allan R.N. Current status and influence of operation on perianal Crohn\u2019s disease. Int J Colorectal Dis 1986; 1 (2): 104\u2014107.","DOI":"10.1007\/BF01648416"},{"key":"key-10.17116\/terarkh201587683-87-14","doi-asserted-by":"crossref","unstructured":"Lichtenstein G.R. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006; 130 (3): 940\u2014987.","DOI":"10.1053\/j.gastro.2006.01.048"},{"key":"key-10.17116\/terarkh201587683-87-15","doi-asserted-by":"crossref","unstructured":"Dejaco C., Harrer M., Waldhoer T. et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn\u2019s disease. Aliment Pharmacol Ther 2003; 18 (11\u201412): 1113\u20141120.","DOI":"10.1046\/j.1365-2036.2003.01793.x"},{"key":"key-10.17116\/terarkh201587683-87-16","doi-asserted-by":"crossref","unstructured":"Colombel J.F., Lemann M., Cassagnou M. et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn\u2019s disease. Groupe d\u2019Etudes Therapeutiquesdes Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol 1999; 94: 674\u2014678.","DOI":"10.1111\/j.1572-0241.1999.935_q.x"},{"key":"key-10.17116\/terarkh201587683-87-17","doi-asserted-by":"crossref","unstructured":"Peyrin-Biroulet L., Lemann M. Review article: remission rates achievable by current therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 870\u2014879.","DOI":"10.1111\/j.1365-2036.2011.04599.x"},{"key":"key-10.17116\/terarkh201587683-87-18","doi-asserted-by":"crossref","unstructured":"Madoff R.D., Fleshman J.W. AGA technical review on the diagnosis and care of patients with anal fissure. Gastroenterology 2003; 124 (1): 235\u2014245","DOI":"10.1053\/gast.2003.50005"},{"key":"key-10.17116\/terarkh201587683-87-19","unstructured":"Shelygin Yu.A., Kashnikov V.N, Bolikhov K.V. i dr. Ileostomiya i ee effektivnost' pri oslozhnennykh formakh BK tolstoi kishki. Koloproktologiya 2012; 3: 41\u201447."},{"key":"key-10.17116\/terarkh201587683-87-20","doi-asserted-by":"crossref","unstructured":"Stange E.F., Travis S.P.L., Vermeire S. et al. European evidence based guidelines on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis. Gut 2006; 55: 16\u201435.","DOI":"10.1136\/gut.2005.081950a"},{"key":"key-10.17116\/terarkh201587683-87-21","doi-asserted-by":"crossref","unstructured":"Carter M.J., Lobo A.J., Travis S.P.L. British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53: 1\u201416.","DOI":"10.1136\/gut.2004.043372"},{"key":"key-10.17116\/terarkh201587683-87-22","unstructured":"Fleisher A.B. Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroid therapy. J Allergy Clin Immunol 2000; 104: 62\u201466."},{"key":"key-10.17116\/terarkh201587683-87-23","doi-asserted-by":"crossref","unstructured":"Wollenberg A., Biber T.F.K. Tacrolimus in: Strategies for immunointerventions in Dermatology. Heiderberg: Springer-Verlag. 1997.","DOI":"10.1007\/978-3-642-60752-3_5"},{"key":"key-10.17116\/terarkh201587683-87-24","doi-asserted-by":"crossref","unstructured":"Colombo M., Bochner B.S., Marone G. Human skin mast cells express functional betal integrins that mediate adhesion to extracellular matrix proteins. J Immunol 1995; 154: 6058\u20146064.","DOI":"10.4049\/jimmunol.154.11.6058"},{"key":"key-10.17116\/terarkh201587683-87-25","doi-asserted-by":"crossref","unstructured":"Panhans-Gro A., Novak N., Kraft S. Human epidermal Largerhans cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 2001; 107: 345\u2014352.","DOI":"10.1067\/mai.2001.112600"},{"key":"key-10.17116\/terarkh201587683-87-26","doi-asserted-by":"crossref","unstructured":"Leung D.Y.M., Soter N.A. Cellular and immunologic mechanisms in atropic dermatitis. J Am Acad Dermotol 2001; 44: S1\u2014S12.","DOI":"10.1067\/mjd.2001.109815"},{"key":"key-10.17116\/terarkh201587683-87-27","unstructured":"Bieber T. Topical tacrolimus (FK506): a new milestone in the management of atopic dermatitis. N Engl J Med 1997; 337: 816\u2014821."},{"key":"key-10.17116\/terarkh201587683-87-28","unstructured":"Jakobovits J., Schuster M.M. Metronidazole therapy for Crohn\u2019s disease and associated fistulae. Am J Gastroenterol 1984; 79: 533\u2014 540."},{"key":"key-10.17116\/terarkh201587683-87-29","doi-asserted-by":"crossref","unstructured":"Fleshner P.R., Schoetz D.J., Roberts P.L. et al. Anal fissure in Crohn\u2019s disease: a plea for aggressive management. Dis Colon Rectum 1995; 38 (11): 1137\u20141143.","DOI":"10.1007\/BF02048328"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:06:44Z","timestamp":1692292004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2015\/6\/downloads\/ru\/380040-366020150614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"alternative-id":["terarkh201587683-87"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201587683-87","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}